MedTrace Logo

Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults

NCT04341168 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2020-04-14

No results posted yet for this study

Summary

The investigators aim to characterise Coronavirus Disease 2019 (COVID-19) in every age group. On the one hand, emphasis is put on the initial presentation, clinical course, outcome and the therapy used. On the other hand further investigations regarding viral and bacterial coinfections, and response of the immune system will be conducted. This study should serve to improve the understanding of COVID-19, to identify risk factors for a severe clinical course and to obtain further insights into pathophysiology of this new infectious disease.

Conditions

Interventions

OTHER

this study is non- interventional

this study is non- interventional

Sponsors & Collaborators

  • Clinic for Internal Medicine I, University Hospital Cologne, Germany

    collaborator UNKNOWN

  • Institute of Virology, University Hospital Cologne, Germany

    collaborator UNKNOWN

  • Center for Molecular Medicine Cologne (CMMC) Cologne, Germany

    collaborator UNKNOWN

  • University Hospital of Cologne

    lead OTHER

Principal Investigators

  • Robert W Körner, Dr. · Children's University Hospital Cologne

  • Miguel A Alejandre Alcazar, Prof. Dr. Dr. · Children's University Hospital Cologne

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-30
Primary Completion
2020-10-31
Completion
2020-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04341168 on ClinicalTrials.gov